Haiyan Yang

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment

Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation

Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study